This results in a significantly lower tumor-to-blood ratio (4.09 ± 0.77 for [68Ga]Ga-AV01084, 4.10 ± 0.88 for [68Ga]Ga-AV01088 and 27.7 ± 6.28 for [68Ga]Ga-PSMA-617) and a lower tumor-to-bone ratio (3.70 ± 0.83 for [68Ga]Ga-AV01084, 3.75 ± 1.28 for [68Ga]Ga-AV01088, and 96.5 ± 47.6 for [68Ga]Ga-PSMA-617). Here, FOLH1 is linked to neoplasm.